Surf Bio is a preclinical biopharmaceutical company that is transforming how antibodies and biologics are delivered to patients. Surf SnapShot™ technology enables mAb concentrations of up to 600 mg/mL and delivery of a dose up to 1,000 mg in a single, standard autoinjector shot. SnapShot’s™ ultra-high concentration formulations are uniquely powered by Surf Bio’s proprietary polymer, enabling one of the most accessible and patient-friendly subcutaneous delivery of mAbs and biologics. For more information about Surf Bio, visit www.surf.bio
| Website | https://www.surf.bio/ |
| Employees | 1 (1 on RocketReach) |
| Phone | +1 408-716-5600 |
| Industry | Biotechnology Research |
| Keywords | Biopharmaceutical, Biologics Delivery, Preclinical Development, Therapeutic Antibodies, Antibody Drug Conjugates, Drug Delivery Technology, Monoclonal Antibodies, Pharmaceutical Development, Protein Therapeutics, Pharmaceutical Research, Drug Product Development, Immunotherapy, Biotechnology, Targeted Drug Delivery, Drug Formulation, Bioprocessing, Clinical Stage, Precision Medicine |
Looking for a particular Surf Bio employee's phone or email?
Bryan Mazlish is the Founder and Chief Executive Officer of Surf Bio.
1 people are employed at Surf Bio.
Surf Bio is based in Palo Alto, California.